Ionpath

🍁 Happy Thanksgiving from all of us at Ionpath! 🍁

🚨 Exciting News! 🚨 𝖶𝖾’𝗋𝖾 𝗍𝗁𝗋𝗂𝗅𝗅𝖾𝖽 𝗍𝗈 𝖺𝗇𝗇𝗈𝗎𝗇𝖼𝖾 𝗍𝗁𝖾 𝗉𝗎𝖻𝗅𝗂𝖼𝖺𝗍𝗂𝗈𝗇 𝗈𝖿 𝗈𝗎𝗋 𝗅𝖺𝗍𝖾𝗌𝗍 𝗉𝖾𝖾𝗋-𝗋𝖾𝗏𝗂𝖾𝗐𝖾𝖽 𝖺𝗋𝗍𝗂𝖼𝗅𝖾 𝗂𝗇 𝗍𝗁𝖾 𝗝𝗼𝘂𝗿𝗻𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗳𝗼𝗿 𝗠𝗮𝘀𝘀 𝗦𝗽𝗲𝗰𝘁𝗿𝗼𝗺𝗲𝘁𝗿𝘆! 🎉 𝖳𝗁𝗂𝗌 𝗌𝗍𝗎𝖽𝗒 𝗁𝗂𝗀𝗁𝗅𝗂𝗀𝗁𝗍𝗌 𝗍𝗁𝖾 𝖽𝖾𝗏𝖾𝗅𝗈𝗉𝗆𝖾𝗇𝗍 𝗈𝖿 𝗱𝗲𝗲𝗽 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗺𝗼𝗱𝗲𝗹𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗠𝗜𝗕𝗜𝘀𝗶𝗴𝗵𝘁 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄, 𝖽𝖾𝗌𝗂𝗀𝗇𝖾𝖽 𝗍𝗈 𝗌𝗂𝗆𝗉𝗅𝗂𝖿𝗒 𝗍𝗁𝖾 𝖺𝗇𝖺𝗅𝗒𝗌𝗂𝗌 𝗈𝖿 𝖼𝗈𝗆𝗉𝗅𝖾𝗑 𝗌𝗉𝖺𝗍𝗂𝖺𝗅 𝗉𝗋𝗈𝗍𝖾𝗈𝗆𝗂𝖼𝗌 𝖽𝖺𝗍𝖺 𝖿𝗋𝗈𝗆 𝗍𝗁𝖾 𝗍𝗎𝗆𝗈𝗋 𝗆𝗂𝖼𝗋𝗈𝖾𝗇𝗏𝗂𝗋𝗈𝗇𝗆𝖾𝗇𝗍 (𝖳𝖬𝖤). 📖 𝖱𝖾𝖺𝖽 𝗍𝗁𝖾 𝖿𝗎𝗅𝗅 𝖺𝗋𝗍𝗂𝖼𝗅𝖾 𝗁𝖾𝗋𝖾: 𝗁𝗍𝗍𝗉𝗌://𝗉𝗎𝖻𝗌.𝖺𝖼𝗌.𝗈𝗋𝗀/𝖽𝗈𝗂/𝖺𝖻𝗌/𝟣𝟢.𝟣𝟢𝟤𝟣/𝗃𝖺𝗌𝗆𝗌.𝟦𝖼𝟢𝟢𝟥𝟤𝟪 𝖠 𝖻𝗂𝗀 𝗍𝗁𝖺𝗇𝗄 𝗒𝗈𝗎 𝗍𝗈 𝗈𝗎𝗋 𝖺𝗆𝖺𝗓𝗂𝗇𝗀 𝗍𝖾𝖺𝗆 𝖺𝗇𝖽 𝖼𝗈𝗅𝗅𝖺𝖻𝗈𝗋𝖺𝗍𝗈𝗋𝗌 𝗐𝗁𝗈 𝗆𝖺𝖽𝖾 𝗍𝗁𝗂𝗌 𝗉𝗈𝗌𝗌𝗂𝖻𝗅𝖾. 𝖲𝗍𝖺𝗒 𝗍𝗎𝗇𝖾𝖽 𝖿𝗈𝗋 𝗆𝗈𝗋𝖾 𝖻𝗋𝖾𝖺𝗄𝗍𝗁𝗋𝗈𝗎𝗀𝗁𝗌!

🚨 𝗔 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗔𝗰𝗵𝗶𝗲𝘃𝗲𝗺𝗲𝗻𝘁: 𝗠𝗜𝗕𝗜𝘀𝗹𝗶𝗱𝗲 𝗕𝗹𝘂𝗲 𝗶𝘀 𝗦𝗵𝗶𝗽𝗽𝗶𝗻𝗴! 🚨 𝖶𝖾 𝖺𝗋𝖾 𝗍𝗁𝗋𝗂𝗅𝗅𝖾𝖽 𝗍𝗈 𝖺𝗇𝗇𝗈𝗎𝗇𝖼𝖾 𝗍𝗁𝖺𝗍 𝗍𝗁𝖾 𝖿𝗂𝗋𝗌𝗍 𝗉𝖺𝖼𝗄𝗌 𝗈𝖿 𝗠𝗜𝗕𝗜𝘀𝗹𝗶𝗱𝗲 𝗕𝗹𝘂𝗲 𝗁𝖺𝗏𝖾 𝗈𝖿𝖿𝗂𝖼𝗂𝖺𝗅𝗅𝗒 𝗌𝗁𝗂𝗉𝗉𝖾𝖽! 𝖤𝗇𝗀𝗂𝗇𝖾𝖾𝗋𝖾𝖽 𝗍𝗈 𝖾𝗇𝗁𝖺𝗇𝖼𝖾 𝗍𝗂𝗌𝗌𝗎𝖾 𝖺𝖽𝗁𝖾𝗌𝗂𝗈𝗇 𝖺𝗇𝖽 𝗆𝗂𝗇𝗂𝗆𝗂𝗓𝖾 𝗂𝗆𝖺𝗀𝗂𝗇𝗀 𝖺𝗋𝗍𝗂𝖿𝖺𝖼𝗍𝗌, 𝖬𝖨𝖡𝖨𝗌𝗅𝗂𝖽𝖾 𝖡𝗅𝗎𝖾 𝖾𝗆𝗉𝗈𝗐𝖾𝗋𝗌 𝗋𝖾𝗌𝖾𝖺𝗋𝖼𝗁𝖾𝗋𝗌 𝗍𝗈 𝖺𝖼𝗁𝗂𝖾𝗏𝖾 𝗍𝗁𝖾 𝖺𝖼𝖼𝗎𝗋𝖺𝖼𝗒 𝖺𝗇𝖽 𝗉𝗋𝖾𝖼𝗂𝗌𝗂𝗈𝗇 𝖾𝗌𝗌𝖾𝗇𝗍𝗂𝖺𝗅 𝖿𝗈𝗋 𝗂𝗆𝗉𝖺𝖼𝗍𝖿𝗎𝗅 𝖽𝗂𝗌𝖼𝗈𝗏𝖾𝗋𝗂𝖾𝗌—𝖽𝖾𝗅𝗂𝗏𝖾𝗋𝗂𝗇𝗀 𝖼𝗅𝖾𝖺𝗋𝖾𝗋 𝖽𝖺𝗍𝖺 𝖺𝗇𝖽 𝗌𝗁𝖺𝗋𝗉𝖾𝗋 𝗂𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝗍𝗈 𝖺𝖽𝗏𝖺𝗇𝖼𝖾 𝗒𝗈𝗎𝗋 𝗂𝗆𝖺𝗀𝗂𝗇𝗀 𝗐𝗈𝗋𝗄𝖿𝗅𝗈𝗐. 𝖤𝗑𝗉𝗅𝗈𝗋𝖾 𝗁𝗈𝗐 𝖬𝖨𝖡𝖨𝗌𝗅𝗂𝖽𝖾 𝖡𝗅𝗎𝖾 𝖼𝖺𝗇 𝖾𝗅𝖾𝗏𝖺𝗍𝖾 𝗒𝗈𝗎𝗋 𝗋𝖾𝗌𝖾𝖺𝗋𝖼𝗁 𝗍𝗈𝖽𝖺𝗒. 📦 #𝖲𝗉𝖺𝗍𝗂𝖺𝗅𝖯𝗋𝗈𝗍𝖾𝗈𝗆𝗂𝖼𝗌 #𝖨𝗇𝗇𝗈𝗏𝖺𝗍𝗂𝗈𝗇 #𝗠𝗜𝗕𝗜𝘀𝗹𝗶𝗱𝗲𝗕𝗹𝘂𝗲

🎉 That’s a Wrap on SITC 2024! 🎉 Thank you to everyone who visited the Ionpath booth at #SITC2024 to engage in insightful discussions, celebrate the launch of MIBIscope 3.0, and enroll in MIBIslide Blue early access. Connecting with researchers, clinicians, and industry leaders who share our commitment to advancing immuno-oncology and pushing the boundaries of spatial biology was truly inspiring. We look forward to continuing these conversations and to another impactful year of collaboration and discovery. See you next year at SITC 2025! #Ionpath #MIBIscope #SpatialBiology #CancerResearch #SITC

🌟 Exciting First Day at SITC! 🌟 Day one at SITC was filled with inspiring talks and invaluable scientific discussions! Our team enjoyed connecting with brilliant minds, and we’re even more excited to continue the conversation today. Visit Booth #1131 to explore the latest advancements with MIBIscope 3.0 and discover MIBIslide Blue, our newest product launch designed to enhance your imaging experience. Our team is here and ready to share how these innovations can power your research. See you there! #SITC2024 #Ionpath #SpatialBiology #MIBIscope3 #MIBIslideBlue

🌟 𝖤𝗑𝖼𝗂𝗍𝗂𝗇𝗀 𝖥𝗂𝗋𝗌𝗍 𝖣𝖺𝗒 𝖺𝗍 𝖲𝖨𝖳𝖢! 🌟 𝖣𝖺𝗒 𝗈𝗇𝖾 𝖺𝗍 𝖲𝖨𝖳𝖢 𝗐𝖺𝗌 𝖿𝗂𝗅𝗅𝖾𝖽 𝗐𝗂𝗍𝗁 𝗂𝗇𝗌𝗉𝗂𝗋𝗂𝗇𝗀 𝗍𝖺𝗅𝗄𝗌 𝖺𝗇𝖽 𝗂𝗇𝗏𝖺𝗅𝗎𝖺𝖻𝗅𝖾 𝗌𝖼𝗂𝖾𝗇𝗍𝗂𝖿𝗂𝖼 𝖽𝗂𝗌𝖼𝗎𝗌𝗌𝗂𝗈𝗇𝗌! 𝖮𝗎𝗋 𝗍𝖾𝖺𝗆 𝖾𝗇𝗃𝗈𝗒𝖾𝖽 𝖼𝗈𝗇𝗇𝖾𝖼𝗍𝗂𝗇𝗀 𝗐𝗂𝗍𝗁 𝖻𝗋𝗂𝗅𝗅𝗂𝖺𝗇𝗍 𝗆𝗂𝗇𝖽𝗌, 𝖺𝗇𝖽 𝗐𝖾’𝗋𝖾 𝖾𝗏𝖾𝗇 𝗆𝗈𝗋𝖾 𝖾𝗑𝖼𝗂𝗍𝖾𝖽 𝗍𝗈 𝖼𝗈𝗇𝗍𝗂𝗇𝗎𝖾 𝗍𝗁𝖾 𝖼𝗈𝗇𝗏𝖾𝗋𝗌𝖺𝗍𝗂𝗈𝗇 𝗍𝗈𝖽𝖺𝗒. 𝖵𝗂𝗌𝗂𝗍 𝖡𝗈𝗈𝗍𝗁 #𝟣𝟣𝟥𝟣 𝗍𝗈 𝖾𝗑𝗉𝗅𝗈𝗋𝖾 𝗍𝗁𝖾 𝗅𝖺𝗍𝖾𝗌𝗍 𝖺𝖽𝗏𝖺𝗇𝖼𝖾𝗆𝖾𝗇𝗍𝗌 𝗐𝗂𝗍𝗁 𝖬𝖨𝖡𝖨𝗌𝖼𝗈𝗉𝖾 𝟥.𝟢 𝖺𝗇𝖽 𝖽𝗂𝗌𝖼𝗈𝗏𝖾𝗋 𝖬𝖨𝖡𝖨𝗌𝗅𝗂𝖽𝖾 𝖡𝗅𝗎𝖾, 𝗈𝗎𝗋 𝗇𝖾𝗐𝖾𝗌𝗍 𝗉𝗋𝗈𝖽𝗎𝖼𝗍 𝗅𝖺𝗎𝗇𝖼𝗁 𝖽𝖾𝗌𝗂𝗀𝗇𝖾𝖽 𝗍𝗈 𝖾𝗇𝗁𝖺𝗇𝖼𝖾 𝗒𝗈𝗎𝗋 𝗂𝗆𝖺𝗀𝗂𝗇𝗀 𝖾𝗑𝗉𝖾𝗋𝗂𝖾𝗇𝖼𝖾. 𝖮𝗎𝗋 𝗍𝖾𝖺𝗆 𝗂𝗌 𝗁𝖾𝗋𝖾 𝖺𝗇𝖽 𝗋𝖾𝖺𝖽𝗒 𝗍𝗈 𝗌𝗁𝖺𝗋𝖾 𝗁𝗈𝗐 𝗍𝗁𝖾𝗌𝖾 𝗂𝗇𝗇𝗈𝗏𝖺𝗍𝗂𝗈𝗇𝗌 𝖼𝖺𝗇 𝗉𝗈𝗐𝖾𝗋 𝗒𝗈𝗎𝗋 𝗋𝖾𝗌𝖾𝖺𝗋𝖼𝗁. 𝖫𝖾𝗍’𝗌 𝗆𝖺𝗄𝖾 𝖽𝖺𝗒 𝗍𝗐𝗈 𝗃𝗎𝗌𝗍 𝖺𝗌 𝗂𝗆𝗉𝖺𝖼𝗍𝖿𝗎𝗅—𝗌𝖾𝖾 𝗒𝗈𝗎 𝗍𝗁𝖾𝗋𝖾! #𝖲𝖨𝖳𝖢𝟤𝟢𝟤𝟦 #𝖨𝗈𝗇𝗉𝖺𝗍𝗁 #𝖲𝗉𝖺𝗍𝗂𝖺𝗅𝖡𝗂𝗈𝗅𝗈𝗀𝗒 #𝖨𝗆𝗆𝗎𝗇𝗈𝗍𝗁𝖾𝗋𝖺𝗉𝗒 #𝖬𝖨𝖡𝖨𝗌𝖼𝗈𝗉𝖾𝟥 #𝖬𝖨𝖡𝖨𝗌𝗅𝗂𝖽𝖾𝖡𝗅𝗎𝖾

𝗛𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 #𝗦𝗜𝗧𝗖𝟮𝟬𝟮𝟰? 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝗜𝗼𝗻𝗽𝗮𝘁𝗵 𝗮𝘁 𝗯𝗼𝗼𝘁𝗵 #𝟭𝟭𝟯𝟭! We’re excited to unveil the latest in spatial biology advancements — including true 3D tissue imaging and cross-platform #omics analyses powered by the new MIBIscope 3.0 & MIBIslide Blue (exclusive Early Access now available)! 📢 𝗕𝗼𝗼𝘁𝗵 𝗧𝗮𝗹𝗸𝘀 𝘄𝗶𝘁𝗵 𝗦𝗲𝗮𝗻 𝗣𝗮𝘄𝗹𝗼𝘄𝘀𝗸𝗶, 𝗣𝗵𝗗 Ionpath Director of Customer Success, Sean Pawlowski, will deliver two insightful presentations at our booth on Nov 8 and 9, each at 3:15 pm. Discover powerful new methods in tissue analysis with these sessions: 1. 𝗧𝗿𝘂𝗲 𝟯𝗗: 𝗛𝗼𝘄 𝘁𝗼 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗲 𝗠𝗼𝗿𝗲 𝗼𝗳 𝗬𝗼𝘂𝗿 𝗧𝗶𝘀𝘀𝘂𝗲 Explore the potential of ToF-SIMS technology to reveal true 3D profiling, unlocking unprecedented insights into the Tumor Microenvironment. Sean will guide attendees through the setup and imaging of 3D tissue analysis, providing a transformative look beyond traditional 2D projections. 2. 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲 𝗬𝗼𝘂𝗿 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗪𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝘄𝗶𝘁𝗵 𝗠𝗜𝗕𝗜𝘀𝗹𝗶𝗱𝗲 𝗕𝗹𝘂𝗲 Learn how MIBIslide Blue revolutionizes Mass Spectral Imaging with the ability to perform multiple imaging modalities on a single tissue sample. This approach maintains data consistency across methods like H&E and MALDI, eliminating the need for sequential slicing. Don’t miss out on these exciting advancements—see you there! #proteomics #genomics #spatial

🎃 𝗡𝗼 𝘁𝗿𝗶𝗰𝗸𝘀, 𝗷𝘂𝘀𝘁 𝘁𝗿𝗲𝗮𝘁𝘀!! Ionpath’s Director of Customer Success, Sean Pawlowski, PhD, will be giving two insightful booth talks you won’t want to miss: 𝗧𝗿𝘂𝗲 𝟯𝗗: 𝗛𝗼𝘄 𝘁𝗼 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗲 𝗠𝗼𝗿𝗲 𝗼𝗳 𝗬𝗼𝘂𝗿 𝗧𝗶𝘀𝘀𝘂𝗲 Discover how ToF-SIMS technology enables true 3D tissue profiling, enhancing depth analysis beyond traditional projections. Sean will dive into setting up a 3D run and imaging it for comprehensive tissue insights, giving you a deeper look into the Tumor Microenvironment (TME). 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲 𝗬𝗼𝘂𝗿 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗪𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝘄𝗶𝘁𝗵 𝗠𝗜𝗕𝗜𝘀𝗹𝗶𝗱𝗲 𝗕𝗹𝘂𝗲 Uncover how the new MIBIslide Blue simplifies Mass Spectral Imaging (MSi) by allowing multiple imaging modalities on a single tissue sample. This innovation ensures data consistency across H&E, MALDI, and other imaging methods—no more reliance on sequential slices. If you’re attending SITC (Nov. 8 & 9), stop by our booth (#1131) for a closer look at these advancements and to connect with the Ionpath team. Let’s advance spatial biology together! ✨🔬

🚀 𝗝𝘂𝘀𝘁 𝗶𝗻 𝘁𝗶𝗺𝗲 𝗳𝗼𝗿 𝗦𝗜𝗧𝗖: 𝗠𝗲𝗲𝘁 𝗠𝗜𝗕𝗜𝘀𝗹𝗶𝗱𝗲 𝗕𝗹𝘂𝗲! 𝖶𝖾’𝗋𝖾 𝗍𝗁𝗋𝗂𝗅𝗅𝖾𝖽 𝗍𝗈 𝗎𝗇𝗏𝖾𝗂𝗅 𝗍𝗁𝖾 𝖿𝗂𝗋𝗌𝗍 𝗅𝗈𝗍 𝗈𝖿 𝖬𝖨𝖡𝖨𝗌𝗅𝗂𝖽𝖾 𝖡𝗅𝗎𝖾—𝖨𝗈𝗇𝗉𝖺𝗍𝗁’𝗌 𝗅𝖺𝗍𝖾𝗌𝗍 𝗂𝗇𝗇𝗈𝗏𝖺𝗍𝗂𝗈𝗇 𝗂𝗇 𝗂𝗆𝖺𝗀𝗂𝗇𝗀 𝗌𝗅𝗂𝖽𝖾 𝗍𝖾𝖼𝗁𝗇𝗈𝗅𝗈𝗀𝗒. Designed for ultra-sensitive tissue adhesion, engineered to minimize artifacts while enhancing image clarity. 𝗪𝗮𝗻𝘁 𝗘𝗮𝗿𝗹𝘆 𝗔𝗰𝗰𝗲𝘀𝘀? 𝖠 𝗅𝗂𝗆𝗂𝗍𝖾𝖽 𝗇𝗎𝗆𝖻𝖾𝗋 𝗈𝖿 𝗌𝗅𝗂𝖽𝖾𝗌 𝖿𝗋𝗈𝗆 𝗈𝗎𝗋 𝖿𝗂𝗋𝗌𝗍 𝗉𝗋𝗈𝖽𝗎𝖼𝗍𝗂𝗈𝗇 𝗋𝗎𝗇 𝖺𝗋𝖾 𝖺𝗏𝖺𝗂𝗅𝖺𝖻𝗅𝖾. 𝖳𝗈 𝗋𝖾𝗌𝖾𝗋𝗏𝖾 𝗒𝗈𝗎𝗋 𝗌𝗅𝗂𝖽𝖾𝗌, 𝗌𝗍𝗈𝗉 𝖻𝗒 𝗍𝗁𝖾 𝖨𝗈𝗇𝗉𝖺𝗍𝗁 𝖻𝗈𝗈𝗍𝗁 (#𝟣𝟣𝟥𝟣) 𝖺𝗍 𝖲𝖨𝖳𝖢. 𝖴𝗇𝗅𝗈𝖼𝗄 𝖼𝗅𝖾𝖺𝗋𝖾𝗋 𝗂𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝗐𝗂𝗍𝗁 𝖬𝖨𝖡𝖨𝗌𝗅𝗂𝖽𝖾 𝖡𝗅𝗎𝖾! #𝖬𝖨𝖡𝖨𝗌𝗅𝗂𝖽𝖾𝖡𝗅𝗎𝖾 #𝖲𝖨𝖳𝖢𝟤𝟢𝟤𝟦 #𝖨𝗈𝗇𝗉𝖺𝗍𝗁 #𝖲𝗉𝖺𝗍𝗂𝖺𝗅𝖯𝗋𝗈𝗍𝖾𝗈𝗆𝗂𝖼𝗌 #𝖨𝗇𝗇𝗈𝗏𝖺𝗍𝗂𝗈𝗇

🔬 𝗙𝗼𝗰𝘂𝘀 𝗼𝗻 𝗣𝗔𝗥𝗣𝟳 𝗣𝗮𝘁𝗵𝘄𝗮𝘆 𝗠𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 🔬 𝖱𝗂𝖻𝗈𝗇 𝗌𝖼𝗂𝖾𝗇𝗍𝗂𝗌𝗍𝗌 𝗂𝗇𝗏𝖾𝗌𝗍𝗂𝗀𝖺𝗍𝖾𝖽 𝗍𝗁𝖾 𝖯𝖠𝖱𝖯𝟩 𝗉𝖺𝗍𝗁𝗐𝖺𝗒 𝗐𝗂𝗍𝗁𝗂𝗇 𝗍𝗁𝖾 𝗍𝗎𝗆𝗈𝗋 𝗆𝗂𝖼𝗋𝗈𝖾𝗇𝗏𝗂𝗋𝗈𝗇𝗆𝖾𝗇𝗍, 𝖽𝗂𝗏𝗂𝗇𝗀 𝖽𝖾𝖾𝗉 𝗂𝗇𝗍𝗈 𝖼𝖾𝗅𝗅𝗎𝗅𝖺𝗋 𝗂𝗇𝗍𝖾𝗋𝖺𝖼𝗍𝗂𝗈𝗇𝗌 𝖺𝗇𝖽 𝗉𝗋𝗈𝗍𝖾𝗂𝗇 𝖾𝗑𝗉𝗋𝖾𝗌𝗌𝗂𝗈𝗇𝗌 𝗍𝗈 𝗎𝗇𝗋𝖺𝗏𝖾𝗅 𝗆𝖾𝖼𝗁𝖺𝗇𝗂𝗌𝗆𝗌 𝗍𝗁𝖺𝗍 𝖽𝗋𝗂𝗏𝖾 𝗍𝗎𝗆𝗈𝗋 𝗉𝗋𝗈𝗀𝗋𝖾𝗌𝗌𝗂𝗈𝗇 𝖺𝗇𝖽 𝗋𝖾𝗌𝗂𝗌𝗍𝖺𝗇𝖼𝖾. 𝖳𝗁𝖾𝗒 𝖿𝗈𝖼𝗎𝗌𝖾𝖽 𝗈𝗇 𝖯𝖠𝖱𝖯𝟩 𝗉𝖺𝗍𝗁𝗐𝖺𝗒 𝗆𝗈𝖽𝗎𝗅𝖺𝗍𝗂𝗈𝗇 𝖺𝗇𝖽 𝗋𝖾𝗏𝖾𝖺𝗅𝖾𝖽 𝗉𝗂𝗏𝗈𝗍𝖺𝗅 𝗂𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝗂𝗇𝗍𝗈 𝗂𝗆𝗆𝗎𝗇𝖾 𝖾𝗏𝖺𝗌𝗂𝗈𝗇 𝗍𝖺𝖼𝗍𝗂𝖼𝗌 𝖾𝗆𝗉𝗅𝗈𝗒𝖾𝖽 𝖻𝗒 𝗍𝗎𝗆𝗈𝗋𝗌, 𝗉𝗈𝗍𝖾𝗇𝗍𝗂𝖺𝗅𝗅𝗒 𝗈𝗉𝖾𝗇𝗂𝗇𝗀 𝗇𝖾𝗐 𝖽𝗈𝗈𝗋𝗌 𝖿𝗈𝗋 𝗍𝖺𝗋𝗀𝖾𝗍𝖾𝖽 𝖼𝖺𝗇𝖼𝖾𝗋 𝗍𝗁𝖾𝗋𝖺𝗉𝗂𝖾𝗌. 𝖳𝗁𝗂𝗌 𝗋𝖾𝗌𝖾𝖺𝗋𝖼𝗁 𝖾𝗑𝖾𝗆𝗉𝗅𝗂𝖿𝗂𝖾𝗌 𝗁𝗈𝗐 𝗌𝗉𝖺𝗍𝗂𝖺𝗅 𝗉𝗋𝗈𝗍𝖾𝗈𝗆𝗂𝖼𝗌 𝖼𝖺𝗇 𝖽𝖾𝗅𝗂𝗏𝖾𝗋 𝖺𝖼𝗍𝗂𝗈𝗇𝖺𝖻𝗅𝖾 𝗂𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝖺𝗇𝖽 𝗂𝗌 𝗁𝖾𝗅𝗉𝗂𝗇𝗀 𝗋𝖾𝗌𝖾𝖺𝗋𝖼𝗁𝖾𝗋𝗌 𝖻𝗋𝗂𝗇𝗀 𝖻𝖾𝗍𝗍𝖾𝗋 𝗉𝖺𝗍𝗂𝖾𝗇𝗍 𝗈𝗎𝗍𝖼𝗈𝗆𝖾𝗌 𝗍𝗈 𝗍𝗁𝖾 𝖿𝗎𝗍𝗎𝗋𝖾 𝗈𝖿 𝗈𝗇𝖼𝗈𝗅𝗈𝗀𝗒. 𝖣𝗂𝗌𝖼𝗈𝗏𝖾𝗋 𝗆𝗈𝗋𝖾 𝖺𝖻𝗈𝗎𝗍 𝖱𝗂𝖻𝗈𝗇'𝗌 𝖿𝗂𝗇𝖽𝗂𝗇𝗀𝗌 𝖺𝗇𝖽 𝗍𝗁𝖾𝗂𝗋 𝗂𝗆𝗉𝖺𝖼𝗍 𝗈𝗇 𝖼𝖺𝗇𝖼𝖾𝗋 𝗋𝖾𝗌𝖾𝖺𝗋𝖼𝗁. 𝗁𝗍𝗍𝗉𝗌://𝗐𝗐𝗐.𝗂𝗈𝗇𝗉𝖺𝗍𝗁.𝖼𝗈𝗆/𝗆𝗂𝖻𝗂-𝖼𝖺𝗌𝖾-𝗌𝗍𝗎𝖽𝗒-𝖼𝖺𝗇𝖼𝖾𝗋-𝗍𝗋𝖾𝖺𝗍𝗆𝖾𝗇𝗍/ #𝖲𝗉𝖺𝗍𝗂𝖺𝗅𝖯𝗋𝗈𝗍𝖾𝗈𝗆𝗂𝖼𝗌 #𝖳𝗎𝗆𝗈𝗋𝖬𝗂𝖼𝗋𝗈𝖾𝗇𝗏𝗂𝗋𝗈𝗇𝗆𝖾𝗇𝗍 #𝖨𝗈𝗇𝗉𝖺𝗍𝗁 #𝖬𝖨𝖡𝖨𝗌𝖼𝗈𝗉𝖾